Colonoscopy may be associated with hypotension during sedation leading to postoperative morbidity. However, no treatment is proven to ameliorate intraoperative hypotension for this procedure. We therefore conducted a randomized trial to determine the effect of intravenous fluid infusion on the incidence of hypotension during sedation for colonoscopy. With institutional approval, 160 patients presenting for elective colonoscopy were randomized to 1.5 ml/kg or 15 ml/kg Hartmann's solution before colonoscopy. All observers were blind to group allocation. The incidence of hypotension during sedation (29% vs 25%; P=0.59) and postoperative morbidity (nausea, vomiting, headache, drowsiness and dizziness) (41% vs 39%; P=0.75) did not differ between the two groups. Hypotensive patients were older, had a higher baseline systolic blood pressure, and were thirstier after fluid infusion than normotensive patients. This study does not support the use of 15 ml/kg Hartmann's solution to reduce the incidence of hypotension or postoperative morbidity in patients undergoing elective colonoscopy.
Colonoscopy is one of the most common medical procedures performed around the world, and is likely to become even more common as the demand for colon cancer screening increases 1 . Containing the workload and cost associated with colonoscopy, whilst ensuring high patient satisfaction, is vital, as patients are ambulatory and require repeat procedures. An intervention that even modestly improves outcomes without greatly increasing costs, therefore, may have a huge impact 2 .
Fasting and bowel preparation may result in significant dehydration, with clinical features including thirst, nausea and vomiting, dizziness, drowsiness and hypotension [3] [4] [5] . In addition, sedation may lead to mild hypotension. We had the impression that hypotension during colonoscopy was quite common in our hospital. Whilst transient hypotension may not lead to adverse outcomes, it usually precipitates repeated measurement and treatment with vasopressors or fluids. However, although intravenous fluid infusion has been shown to improve some outcomes following ambulatory surgery [5] [6] [7] [8] or bowel preparation 3, 4 , the effectiveness of intravenous fluids in improving outcomes after colonoscopy has not been studied. Furthermore, fluid infusion has the potential to increase the workload and costs of providing care for this very large group of patients.
We therefore tested the hypothesis that intravenous fluid infusion would decrease the incidence of hypotension in patients presenting for elective outpatient colonoscopy.
METHoDs
With the approval of our Human Research Ethics Committee, we conducted a pilot study and a randomized, double-blind, controlled clinical trial. Patients in both studies were asked to take all routine medications except for oral hypoglycaemic agents, and were asked to fast for solids for 24h and for fluids for 6h. sedation for endoscopy is routinely administered and monitored by anaesthetists in our hospital. The type of bowel preparation is prescribed according to endoscopist preference.
Pilot study
The pilot study was conducted in 200 patients to determine the incidence of hypotension during colonoscopy at our hospital and therefore deter-mine an appropriate sample size for a randomized trial. All patients presenting for elective outpatient colonoscopy, who received oral bowel preparation, were eligible. Intravenous fluids are not routinely administered to these patients at our hospital. Patients who did receive prophylactic intravenous fluids, or who had contraindication to rapid intravenous infusion (e.g. uncontrolled cardiac failure or renal failure) were excluded. Informed consent was not obtained as the Ethics Committee considered that this was audit. Blood pressure was measured 2.5minutely using automated non-invasive measurement (As/3, Datex-ohmeda, Finland). Hypotension was defined as a decrease in systolic blood pressure (sBP) from baseline of ≥25% (the 'hypotensive' group). one reading was sufficient to define hypotension for the purposes of the study. Based on our experience, we estimated that the incidence of hypotension was 50%. By including 200 patients, we estimated that the probability that hypotension would occur in 43 to 57% of patients would be 95%. The incidence of hypotension in the pilot study was 45%. Therefore, the sample size required for the randomized trial to detect a 50% reduction in the incidence of hypotension, was 80 patients per group (a=0.05, b=0.2).
Randomized controlled trial
Male and female patients, aged >18 years and presenting for elective outpatient colonoscopy following full bowel preparation were recruited for the randomized trial. All provided written informed consent. Exclusion criteria included inadequate English language comprehension due to a language barrier, cognitive deficit or intellectual disability, prior intravenous fluid therapy, and a contraindication to rapid intravenous infusion (e.g. uncontrolled cardiac failure or renal failure).
Patients were randomized to receive intravenous Hartmann's solution 1.5 ml/kg (low volume group: to assist with blinding) or 15 ml/kg (high volume group). Randomization was determined using a computergenerated list and randomization results were concealed in envelopes until after written informed consent was obtained. Patients, anaesthetists, endoscopists and observers were blind to group allocation. one of the investigators inserted a 22 gauge intravenous cannula into a large forearm vein and infused the Hartmann's solution over 20 minutes immediately prior to colonoscopy. The fluid infusion was concealed from view by an opaque plastic bag and the investigator removed the infusion bag and tubing when completed prior to colonoscopy to ensure blinding. Fentanyl 1 µg/kg IV and propofol approximately 1 mg/kg followed by 5 mg/kg/h were administered to achieve and maintain an observer's Assessment of Alertness/sedation (oAA/s) score of 3 (responsive to mild prodding) 9 and colonoscopy was commenced. This depth of sedation is customary at our hospital. oxygen 4 l/min was administered via a Hudson mask. We asked anaesthetists to consider administering metaraminol 0.5 mg IV, if the sBP decreased below 85 mmHg. At the conclusion of the procedure, patients were transferred to the post-anaesthesia care unit (PACU). Data were collected until two hours after the procedure.
Baseline data included age, sex, weight, American society of Anesthesiologists' (AsA) physical status, type of bowel preparation (hypertonic or isotonic), clinical diagnosis of hypertension, ischaemic heart disease, cardiac arrhythmia or cardiac failure, fasting time for solids and fluids and quality of recovery (QoR score: a validated 9-item questionnaire with a minimum score of zero and a maximum score of 18 10 ). Arterial blood pressure was measured non-invasively and sBP was recorded prior to fluid infusion, following fluid infusion, every 2.5 min during sedation, and in the PACU. Thirst was measured using a 100 mm visual analogue scale (VAs) (0=no thirst at all; 100= extremely thirsty) prior to fluid infusion, immediately following fluid infusion, but before sedation, and in the PACU. oAA/s scores, sedative drug doses and duration of sedation were recorded. In the PACU, a modified Aldrete score 11 , QoR score, presence or absence of nausea, vomiting, headache, drowsiness or dizziness before discharge, and time to hospital discharge were recorded.
Statistical Analyses
Continuous variables were graphed to assess their distribution. Normally distributed variables were summarized using mean±standard deviation, skewed variables using median (range) and categorical variables using number (%). Comparisons were made using student's t-tests (normally distributed variables), Wilcoxon rank sum test (skewed variables), c 2 -squared test or Fisher's exact test (categorical variables). survival data (such as time to discharge) were assessed using the log-rank test. Changes in sBP and VAs scores for thirst were assessed using repeated measures analysis of variance. Univariate predictors with P values <0.2 were included in multivariate logistic regression models, and finally parsimonious models were created. All statistical analyses were undertaken using stata 8.0 (stata Corporation, College station, TX, U.s.A.); P<0.05 was considered statistically significant.
REsULTs
In all, 325 patients underwent colonoscopy during the study period. Eighty-two did not speak English or could not consent, 62 refused participation and 21 had either congestive cardiac failure or end-stage renal failure, leaving 160 recruited patients.
Baseline characteristics were similar between the low and high volume groups (Table 1) . Twenty-three per cent of patients reported preoperative hypertension. Although patients had been fasting, VAs scores indicated only a moderate amount of thirst.
There were no significant differences between the two groups after fluid infusion ( Table 2 ). The incidence of hypotension during sedation was 29% in the low volume group and 25% in the high volume group (P=0.59). Absolute (-23±20 vs -21±19 mmHg; P= 0.56) and percentage (-17±14% vs -16±14%; P= 0.59) decreases in sBP from baseline during sedation were similar in the low and high volume groups. Nine patients in the low volume group and 11 patients in the high volume group recorded a sBP <85 mmHg, but only one patient in each group received vasopressor treatment. There were no significant differences between the two groups in the PACU. Patients with one or more postoperative symptoms (nausea, vomiting, headache, dizziness or drowsiness) took longer to reach an Aldrete score >9 than patients without symptoms (8 Patients who fulfilled our definition of 'hypotension' (hereafter referred to as 'hypotensive' even if treatment was not required) were significantly older than those defined as 'normotensive', and had higher baseline sBP. 'Hypotensive' patients had higher VAs scores for thirst after fluid administration than 'normotensive' patients. Although sedation scores were similar, the rate of propofol infusion was lower in the 'hypotensive' group than the 'normotensive' group. However, after adjustment, only age and baseline sBP were significant predictors of hypotension (Table  3) . seventy percent of patients defined as "hypotensive" recorded a sBP <100 mmHg during sedation compared with 30% of patients in the "normotensive" group.
Patients in the pilot study were older (56±17 vs 51±15 years; P=0.001), had higher AsA scores (32% AsA 3 vs 10% AsA 3; P<0.0001), more cardiovascular co-morbidities (43% vs 26%; P=0.001) and higher baseline sBP (140±25 vs 129±19 mmHg; P<0.0001) than patients in the randomized trial. The incidence of hypotension was significantly greater in the pilot study than in the randomized trial (45% vs 27%; P=0.001).
DIsCUssIoN
This study does not support routine intravenous infusion of 15 ml/kg of Hartmann's solution to prevent hypotension during sedation, or to reduce postoperative thirst, nausea and vomiting, headache, drowsiness, or dizziness in patients undergoing elective outpatient colonoscopy.
There are several possible explanations for our results, apart from lack of effectiveness of our study treatment. Firstly, the volume infused could have been insufficient. This possibility is supported by the fact that hypotensive patients had higher VAs scores for thirst than normotensive patients after infusion. We chose 15 ml/kg because it represented about one litre of fluid, a convenient volume to infuse through a small-gauge intravenous cannula before colonoscopy. Previous studies in ambulatory surgery patients reported that infusion of more than one litre of fluid reduced the incidence of drowsiness and dizziness, but the effects on nausea, vomiting, headache and thirst were inconsistent, and intraoperative haemodynamics were not assessed [5] [6] [7] [8] [12] [13] [14] . Whether larger volumes are more effective at preventing hypotension during sedation for colonoscopy therefore requires further study. In addition, alternative methods for reducing the incidence of hypotension during colonoscopy could be assessed, such as reduc-ing fasting times for fluids and encouraging greater oral intake 15, 16 or reducing the doses of sedative medication administered.
secondly, a 'hypotensive' group may have been created by our definition where no true hypotension existed and so fluid infusion had no effect. In addition, we defined a 'hypotensive' group based on one blood pressure reading. Previous studies on the incidence of hypotension during colonoscopy have defined hypotension variously [17] [18] [19] [20] . We chose a definition that we believed represented a threshold triggering action to be taken by the anaesthetist. This definition resulted in patients with higher baseline sBP being more likely to become 'hypotensive'. However, 70% of hypotensive patients recorded a sBP <100 mmHg during sedation, indicating that the 'hypotensive' patients indeed had significant hypotension that would provoke repeated measurement and possibly treatment. on the other hand, patients rarely received treatment for hypotension, suggesting that the hypotension was short-lived or not considered important by the anaesthetists. The suggestion from our data that older, hypertensive patients may be a subset that could benefit from prophylactic fluid infusion requires further study.
Thirdly, the incidence of hypotension was lower in the randomized trial (27%) than in our pilot study (45%). As a result the randomized trial was underpowered to demonstrate a 50% reduction in the incidence of hypotension with fluid infusion. Patients who could not consent because of a language barrier or cognitive deficit were included in the pilot study, but not the randomized trial, excluding a group of older patients with more cardiovascular comorbidities from the randomized trial [21] [22] [23] . As a result of these factors, the incidence of hypotension and generalizability of our results thereby were reduced. However, there was no suggestion from our data that the rate of hypotension was different between the two groups (29% in the low volume group vs 25% in the high volume group [P=0.59]). Routine prophylactic fluid infusion to prevent postoperative morbidity also cannot be justified by our results. The incidence of the postoperative symptoms that we measured in our patients was low and was not different between the two groups. The quality of recovery scores were high, and discharge times were short. Whilst the postoperative symptoms prolonged recovery time, this difference was not clinically significant, and total hospital stays were similar 24 . However, our study was not powered to address these endpoints and the many statistical comparisons in these exploratory analyses could lead to spurious conclusions of significance, because of an inflated type I error. Borderline results therefore should be interpreted with care.
In conclusion, prophylactic intravenous fluid infusion did not prevent hypotension during sedation or any postoperative symptom in patients undergoing elective colonoscopy.
